Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

3 clinical studies listed.

Filters:

Drug Safety

Tundra lists 3 Drug Safety clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT06573489

Efficacy and Safety of Fospropofol in Adult Laparoscopic Surgery: A Clinical Trial

This protocol is a clinical study of fospropofol disodium for general anesthesia in adults undergoing laparoscope-assisted abdominal surgery. The study has three main objectives: First, to explore the use of propofol disodium as the lowest effective dose for induction of general anesthesia; Secondly, to evaluate the efficacy and safety of fospropofol disodium in the maintenance phase of general anesthesia, and to determine its effective dose range; Finally, the effects of fospropofol disodium on Bispectral Index during induction, maintenance and recovery were studied, and compared with propofol to understand its characteristic changes. The randomized, single-blind, controlled design of the study, with an expected enrollment of 373 patients, was designed to achieve its objectives through a three-phase trial design to provide important clinical information about the safety and efficacy of the use of propofol disodium.

Gender: All

Ages: 18 Years - 65 Years

Updated: 2025-04-16

1 state

Drug Safety
NOT YET RECRUITING

NCT06889376

Use of Intranasal Midazolam to Reduce Stress and Procedural Pain in Premature Infants During Routine ROP Examination.

The goal of this study is to learn about the safety and effectiveness of intranasal midazolam in newborns and infants born prematurely, undergoing Retinopathy of Prematurity (ROP) screening. The main question it aims to answer is: • Does use of intranasal midazolam is a safe, quick, non-invasive medication, that reduces the pain, stress, discomfort, and other complications in patients undergoing ROP screening? Researchers will compare the intervention group with a comparison group of the patients who will receive routine comfort care.

Gender: All

Ages: Any - 30 Weeks

Updated: 2025-03-21

Drug Safety
ACTIVE NOT RECRUITING

NCT01722916

Reducing and Removing Hyaluronic Acid Filler With Hyaluronidase

The purpose of this study is to find how much hyaluronidase should be used when receiving injections of fillers.

Gender: All

Ages: 18 Years - 65 Years

Updated: 2025-01-31

1 state

Drug Safety